- Report
- October 2025
- 196 Pages
Global
From €4511EUR$4,995USD£3,865GBP
- Report
- July 2026
- 160 Pages
Global
From €2998EUR$3,320USD£2,569GBP
€3748EUR$4,150USD£3,211GBP
- Report
- July 2026
- 160 Pages
Global
From €2998EUR$3,320USD£2,569GBP
€3748EUR$4,150USD£3,211GBP
- Report
- October 2025
- 160 Pages
Global
From €2854EUR$3,160USD£2,445GBP
€3567EUR$3,950USD£3,057GBP
- Report
- October 2025
- 160 Pages
Global
From €2854EUR$3,160USD£2,445GBP
€3567EUR$3,950USD£3,057GBP
- Report
- May 2026
- 149 Pages
Global
From €3567EUR$3,950USD£3,057GBP
- Report
- January 2026
- 148 Pages
Global
From €3567EUR$3,950USD£3,057GBP
- Report
- August 2026
- 160 Pages
Global
From €2998EUR$3,320USD£2,569GBP
€3748EUR$4,150USD£3,211GBP
- Report
- May 2026
- 145 Pages
Global
From €3567EUR$3,950USD£3,057GBP
- Report
- May 2026
- 154 Pages
Global
From €3567EUR$3,950USD£3,057GBP
- Report
- May 2026
- 151 Pages
Global
From €3567EUR$3,950USD£3,057GBP
- Report
- May 2026
- 146 Pages
Global
From €3567EUR$3,950USD£3,057GBP
- Report
- January 2026
- 147 Pages
Global
From €3567EUR$3,950USD£3,057GBP
- Report
- April 2026
- 167 Pages
Global
From €4380EUR$4,850USD£3,753GBP
- Report
- March 2026
- 198 Pages
Global
From €4380EUR$4,850USD£3,753GBP
- Report
- March 2026
- 255 Pages
Global
From €4380EUR$4,850USD£3,753GBP
- Report
- February 2026
- 150 Pages
Global
From €4380EUR$4,850USD£3,753GBP
- Report
- December 2025
- 150 Pages
Global
From €4380EUR$4,850USD£3,753GBP
- Report
- October 2025
- 150 Pages
Global
From €4380EUR$4,850USD£3,753GBP
- Report
- May 2026
- 150 Pages
Global
From €4380EUR$4,850USD£3,753GBP

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more